Systemic levels of human β-defensin 1 are elevated in patients with cirrhosis

 
This item is provided by the institution :

Repository :
Annals of Gastroenterology
see the original item page
in the repository's web site and access all digital files if the item*
share




2016 (EN)
Systemic levels of human β-defensin 1 are elevated in patients with cirrhosis (EN)

Karagiannakis, Dimitris
Siakavellas, Spyros I.
Ladas, Spiros D.
Kaltsa, Garyfallia
Vafiadi, Irene
Goukos, Dimitris
Michopoulos, Spyridon
Daikos, George L.
Zampeli, Evanthia
Vlachogiannakos, Jiannis
Bamias, Giorgos

Background Bacterial translocation (BT) commonly occurs in cirrhosis. Reliable biomarkers for BT are currently lacking. Human beta defensin-1 (hBD-1) is a member of the family of natural antimicrobial peptides produced by epithelial cells and participates in the mucosal defensive mechanisms that prevent BT. The aim of the present study was to examine the local and systemic expression of hBD-1 in patients with cirrhosis.Methods Plasma concentrations of hBD-1 and of soluble CD14 (sCD14) proteins were measured by ELISA in patients with chronic viral hepatitis, cirrhosis, and healthy controls. Relative mRNA expression of various natural antimicrobial peptides was determined by real-time PCR in biopsies from the terminal ileum and colon.Results We found significant upregulation of hBD-1 and sCD14 in the peripheral blood of patients with cirrhosis compared to patients with chronic viral hepatitis and healthy controls. The etiology of cirrhosis did not affect the concentration of either protein. The levels of hBD-1 protein correlated significantly with the levels of sCD14 in blood collected from hepatic veins of cirrhotic patients. In contrast, no significant differences were observed in the intestinal mucosal mRNA expression of the Paneth cell specific defensin A5 or hBD-1 between patients with cirrhosis and healthy controls.Conclusions hBD-1 is upregulated in patients with cirrhosis and highly correlates with the lipopolysaccharide-induced protein sCD14. hBD-1 may serve as a biomarker of BT in patients with cirrhosis.Keywords Cirrhosis, bacterial translocation, human beta defensin-1, soluble CD14, natural antimicrobial peptides, biomarkersAnn Gastroenterol 2016; 29 (1): 63-70 (EN)

info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

Ελληνική Γαστροεντερολογική Εταιρία (EL)
Hellenic Society of Gastroenterology (EN)

2016-01-07


Hellenic Society of Gastroenterology (EN)

1792-7463
1108-7471
Annals of Gastroenterology; Volume 29, No 1 (2016); 63 (EN)



*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)